Human
How does tirzepatide compare with semaglutide for weight loss?
20.2% weight reduction72 weeks; maximum tolerated tirzepatide 10/15 mg versus semaglutide 1.7/2.4 mg; adults without diabetes.
Demonstrated findings
Average body-weight reduction was 20.2% with tirzepatide and 13.7% with semaglutide at 72 weeks.
What might this mean? ยท interpretation
This direct comparison favors tirzepatide for the tested weight-loss outcome and regimens.
What might this mean, and what would change the interpretation?
Adults with obesity without diabetes; open-label trial. It does not compare all doses or establish an overall winner for every health outcome.
What would clarify this: Longer follow-up and comparisons covering body composition, tolerability and clinical outcomes.